A former New Orleans Police Department sergeant affectionately known as the “dancing cop” has died after developing ALS. Leroy-Joseph "L.J." Compascio Smith, 58, died Feb. 21. He’d been ...

Background Spasticity is common among people with multiple sclerosis (MS), but there are few studies of spasticity treatment patterns. We aim to describe associations with spasticity treatment ...

Understanding the pathophysiology of spasticity and its clinical presentations are crucial for healthcare professionals to effectively address this challenging condition. While the exact ...

Amyotrophic lateral sclerosis (ALS) is a fatal disease, characterized by the degeneration of both upper and lower motor neurons. Despite decades of research, we still to date lack a cure or disease ...

Aim: Many studies have been performed on the methodological qualities of the (modified) Ashworth Scale but overall these studies seem inconclusive. The aim of this study was to investigate the ...

Researchers have made a significant advancement in the field of spinal cord injury research, developing a novel optogenetic mouse model that could lead to improved treatments for limb spasticity.

MONTPELLIER, France — French researchers have identified a blood test that could revolutionize how amyotrophic lateral sclerosis (ALS) is diagnosed and monitored. A team from Montpellier has shown ...

Measuring blood levels of neurofilament light chain, or NfL, a biomarker of nerve damage, may help in diagnosing amyotrophic lateral sclerosis (ALS), and in predicting the risk of death among people ...

PrimeC has been given an ‘Orphan Drug’ status by the FDA (Food and Drug Administration) and EMA (European Medicines Agency). PrimeC is a novel therapy with a multi-targeted approach to treat ALS.

The test also provided insight into how quickly the disease would act upon patients THURSDAY, Feb. 27, 2025 (HealthDay News) -- A blood test can help doctors detect ALS, or amyotrophic lateral ...

Clene is collaborating with APST Research to further explore how CNM-Au8 affects levels of neurofilament light chain (NfL) among amyotrophic lateral sclerosis (ALS) patients being treated in expanded ...